Found: 10
Select item for more details and to access through your institution.
Virologic Response to Dolutegravir Plus Lamivudine in People With Suppressed Human Immunodeficiency Virus Type 1 and Historical M184V/I: A Systematic Literature Review and Meta-analysis.
- Published in:
- Open Forum Infectious Diseases, 2023, v. 10, n. 11, p. 1, doi. 10.1093/ofid/ofad526
- By:
- Publication type:
- Article
Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance.
- Published in:
- Open Forum Infectious Diseases, 2022, v. 9, n. 11, p. 1, doi. 10.1093/ofid/ofac610
- By:
- Publication type:
- Article
Superior neutralizing response after first versus second SARS‐CoV‐2 infection in fully vaccinated individuals.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 11, p. 1, doi. 10.1002/jmv.29225
- By:
- Publication type:
- Article
Cross neutralization of SARS‐CoV‐2 omicron subvariants after repeated doses of COVID‐19 mRNA vaccines.
- Published in:
- Journal of Medical Virology, 2023, v. 95, n. 1, p. 1, doi. 10.1002/jmv.28268
- By:
- Publication type:
- Article
Use of Tenofovir Alafenamide/Emtricitabine/Elvitegravir-Cobicistat in HIV-Naive Patients with Advanced Disease: GENIS Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 17, p. 4994, doi. 10.3390/jcm11174994
- By:
- Publication type:
- Article
Neutralizing Response Against SARS-CoV-2 Variants 8 Months After BNT162b2 Vaccination in Naive and COVID-19–Convalescent Individuals.
- Published in:
- Journal of Infectious Diseases, 2022, v. 225, n. 11, p. 1905, doi. 10.1093/infdis/jiab634
- By:
- Publication type:
- Article
Effectiveness and tolerability of dolutegravir/lamivudine for the treatment of HIV-1 infection in clinical practice.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2023, v. 78, n. 6, p. 1423, doi. 10.1093/jac/dkad102
- By:
- Publication type:
- Article
Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study).
- Published in:
- 2021
- By:
- Publication type:
- journal article
Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Effectiveness of boosted darunavir plus rilpivirine in patients with long-lasting HIV-1 infection: DARIL study.
- Published in:
- 2020
- By:
- Publication type:
- journal article